Código QR (código de barras bidimensional)

Cost drivers in the pharmacological treatment of interstitial lung disease

Abstract Introduction Treatments of interstitial lung diseases (ILDs) mainly focus on disease stabilization and relief of symptoms by managing inflammation or suppressing fibrosis by (in part costly) drugs. To highlight economic burden of drug treatment in different ILD-subtypes we assessed cost tre...

ver descrição completa

Na minha lista:
Principais autores: Phillen Nozibuyiso Maqhuzu, Michael Kreuter, Thomas Bahmer, Nicolas Kahn, Martin Claussen, Rolf Holle, Larissa Schwarzkopf
Formato: Artigo
Idioma:Inglês
Publicado em: BMC 2021-08-01
coleção:Respiratory Research
Assuntos:
Diffuse parenchymal lung disease
Healthcare expenditure
Direct costs
ILD management
Healthcare spending
Acesso em linha:https://doi.org/10.1186/s12931-021-01807-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados